Boston Research & Management Inc / MDT
Boston Research & Management Inc’s Medtronic PLC Position
Does Boston Research & Management Inc own Medtronic PLC (MDT)? Yes — 50.5K shares worth $4M (+1.04% of its 13F portfolio) as of Q1 2026, up from 49.0K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
50.5K
% of Portfolio
+1.04%
Quarters Held
29
currently held
Position History MDT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 50.5K | $4M | +1.04% |
| Q4 2025 | 49.0K | $5M | +1.09% |
| Q3 2025 | 50.8K | $5M | +1.07% |
| Q2 2025 | 50.5K | $4M | +1.05% |
| Q1 2025 | 48.5K | $4M | +1.08% |
| Q4 2024 | 50.9K | $4M | +1.00% |
| Q3 2024 | 51.0K | $5M | +1.08% |
| Q2 2024 | 48.5K | $4M | +0.96% |
| Q1 2024 | 47.9K | $4M | +1.03% |
| Q4 2023 | 47.1K | $4M | +1.03% |
| Q3 2023 | 53.5K | $4M | +1.24% |
| Q2 2023 | 53.0K | $5M | +1.32% |
| Q1 2023 | 52.5K | $4M | +1.26% |
| Q4 2022 | 48.2K | $4M | +1.16% |
| Q3 2022 | 51.0K | $4M | +1.40% |
| Q2 2022 | 47.5K | $4M | +1.38% |
| Q1 2022 | 46.3K | $5M | +1.49% |
| Q4 2021 | 45.0K | $5M | +1.27% |
| Q3 2021 | 46.0K | $6M | +1.72% |
| Q2 2021 | 45.7K | $6M | +1.72% |
| Q1 2021 | 46.2K | $5M | +1.76% |
| Q4 2020 | 44.3K | $5M | +1.81% |
| Q3 2020 | 44.5K | $5M | +1.81% |
| Q2 2020 | 45.7K | $4M | +1.74% |
| Q1 2020 | 44.3K | $4M | +2.01% |
| Q4 2019 | 44.6K | $5M | +1.90% |
| Q3 2019 | 44.7K | $5M | +1.92% |
| Q2 2019 | 44.9K | $4M | +1.77% |
| Q1 2019 | 44.2K | $4M | +1.68% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boston Research & Management Inc’s full portfolio or all institutional holders of MDT.